Rivoceranib-Camrelizumab
![Elevar Therapeutics, Rivoceranib-Camrelizumab, Liver Cancer, FDA](https://pharmtales.com/wp-content/uploads/2023/07/Elevar-Therapeutics-Announces-FDA-Acceptance-of-Rivoceranib-Camrelizumab-Combo-for-Liver-Cancer.jpg)
Elevar Therapeutics Announces FDA Acceptance of Rivoceranib-Camrelizumab Combo for Liver Cancer
SG Tylor
On July 17, 2023 Elevar Therapeutics, a fully integrated biopharmaceutical company focused on improving treatment options for patients with limited ...